PFM Health Sciences’s Compass Pathways CMPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Sell
247,589
-1,119,510
-82% -$11.4M 0.3% 79
2026
Q1
$7.56M Buy
1,367,099
+587,481
+75% +$3.95M 0.69% 47
2025
Q4
$5.38M Sell
779,618
-883,218
-53% -$5.39M 0.54% 51
2025
Q3
$9.53M Sell
1,662,836
-116,423
-7% -$523K 0.73% 40
2025
Q2
$4.98M Buy
1,779,259
+1,327,992
+294% +$5M 0.42% 41
2025
Q1
$1.29M Hold
451,267
0.09% 56
2024
Q4
$1.71M Hold
451,267
0.11% 74
2024
Q3
$2.84M Sell
451,267
-638,325
-59% -$4.5M 0.16% 62
2024
Q2
$6.58M Hold
1,089,592
0.33% 53
2024
Q1
$9.07M Buy
1,089,592
+750,831
+222% +$7.57M 0.43% 56
2023
Q4
$2.96M Buy
338,761
+285,890
+541% +$1.85M 0.18% 58
2023
Q3
$391K Sell
52,871
-122,410
-70% -$1.08M 0.02% 72
2023
Q2
$1.45M Sell
175,281
-70,783
-29% -$601K 0.06% 78
2023
Q1
$2.44M Sell
246,064
-263,561
-52% -$2.43M 0.11% 70
2022
Q4
$4.09M Buy
509,625
+111,914
+28% +$1.12M 0.15% 75
2022
Q3
$4.27M Buy
397,711
+4,947
+1% +$74.1K 0.15% 77
2022
Q2
$4.25M Buy
+392,764
New +$3.96M 0.16% 77

Other funds holding CMPS

PFM Health Sciences's CMPS Position: Q2 2026 in Review

PFM Health Sciences reduced its Compass Pathways (CMPS) stake by 82% in Q2 2026, selling an estimated $11.4M and leaving 247,589 shares worth $3.5M. The position accounts for 0.3% of the portfolio, ranked #79.

PFM Health Sciences first reported a position in CMPS in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.53M in Q3 2025. 223 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.

  • PFM Health Sciences held 247,589 shares of Compass Pathways worth $3.5M as of Q2 2026.
  • PFM Health Sciences sold 1,119,510 Compass Pathways shares in Q2 2026, an estimated $11.4M.
  • Compass Pathways made up 0.3% of PFM Health Sciences's portfolio in Q2 2026, its #79 holding.
  • PFM Health Sciences first reported a position in Compass Pathways in Q2 2022 and has held it in 17 quarters since.
  • PFM Health Sciences's Compass Pathways position peaked at $9.53M in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.